Clinical Laboratory Improvement Advisory Committee
This article was originally published in The Gray Sheet
Executive Summary
Meeting will be held May 26-27 at the Centers for Disease Control and Prevention in Atlanta. The committee plans to review the criteria for placing tests in the waived category under the Clinical Laboratory Improvement Amendments of 1988 but will not discuss specific tests. The panel is accepting public comment on the subject until April 30. For further information contact Henry Colvin of the CDC at 404/639-1706.